ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW)

CUSIP: G6780C117

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / *W EXP 04/15/202
Total 13F shares
2,539,603
Share change
+53,806
Total reported value
$693,567
Price per share
$0.15
Number of holders
26
Value change
+$1,163
Number of buys
4
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G6780C117?
CUSIP G6780C117 identifies ORIAW - ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW) as of Q4 2022

As of 31 Dec 2022, ORION BIOTECH OPPORTUNTES CO - *W EXP 04/15/202 (ORIAW) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,539,603 shares. The largest 10 holders included Periscope Capital Inc., GRITSTONE ASSET MANAGEMENT LLC, 683 Capital Management, LLC, KIM, LLC, MMCAP International Inc. SPC, Linden Advisors LP, Shaolin Capital Management LLC, CANTOR FITZGERALD, L. P., Arena Capital Advisors, LLC- CA, and HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.